Northwire Canada EditionSunday, July 12, 2026
Sign inSubscribe
Northwire
⌕
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%

Healthcare

Page 22
  1. May 08, 2026 · 06:26 · 4565 · Routine +

    Nxera Pharma Defends Core IP Amidst Profitability Turnaround

    Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology

    01
  2. May 07, 2026 · 17:55 · VHI · Routine +

    Q1 Revenue Surges 47%

    VitalHub Reports First Quarter 2026 Results

    02
  3. May 07, 2026 · 17:24 · EXE · Material +

    Extendicare’s Investment-Grade Debut and CBI Close Cement a Transformative Growth Trajectory

    Extendicare Announces 2026 First Quarter Results

    03
  4. May 07, 2026 · 17:00 · NLH · Routine +

    Nova Leap’s Q1 shines with record TTM revenue and a bolt-on Nova Scotia acquisition, but the small-cap story still needs to prove scalability beyond the home.

    Nova Leap Health Corp. Posts Q1 2026 Results

    04
  5. May 07, 2026 · 17:00 · CPH · Routine +

    Cipher Goes Debt-Free and Boasts $71M in Dry Powder, But Stagnant Sales Raise the Bar for Deal-Driven Growth

    Cipher Pharmaceuticals Reports First Quarter Results

    05
  6. May 07, 2026 · 16:05 · PRN · Material +

    Humana coverage and surging procedure volumes push TULSA-PRO toward standard of care, but path to profitability still requires execution.

    Profound Medical Reports Strong First Quarter 2026 Financial Results

    06
  7. May 07, 2026 · 16:01 · WELL · Routine +

    WELL Health Q1 Earnings Beat Revenue Targets But Cash Flow Divergence Raises Liquidity Concerns

    WELL Health Delivers Record Q1-2026 with Canadian Clinics Run Rate Exceeding $500M and Revenue Up 25% to $368M

    07
  8. May 07, 2026 · 07:31 · BPC · Routine +

    Peptide Patch Progress Tests Investor Patience Amid Capital Burn

    The Precision Peptide Company Nears Commercial Launch of Needle-Free BPC-157 Patch as Final Testing Advances

    08
  9. May 07, 2026 · 07:30 · UDOC · Routine +

    Legacy Asset Relaunch Fails to Halt Dilution-Driven Decline in Rural eHealth Play

    UniDoc to Update and Relaunch Legacy eHealth Systems with Pawnee Mental Health Services Across Rural Kansas

    09
  10. May 07, 2026 · 07:30 · BCT · Routine +

    BriaCell Therapeutics Corp

    BriaCell Adds NYU Langone Health's Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

    10
  11. May 07, 2026 · 07:27 · CRDL · Routine +

    Cardiol Therapeutics Validates Pilot Data Amidst Pivotal Trial Progress, Yet Market Remains Cautious on Phase III Readout

    Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association

    11
  12. May 07, 2026 · 07:25 · KNE · Routine −

    Kane Biotech Seeks $1M Amidst Revenue Slump and Cash Burn Concerns

    Kane Biotech Announces New Private Placement Offering

    12
  13. May 07, 2026 · 07:15 · ASG · Routine +

    Patent Milestone Masks Cash Strain and Debt Overhang Despite EBITDAC Turnaround

    Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology(TM) Bone Density-Matched Implants

    13
  14. May 07, 2026 · 07:00 · DR · Material +

    Medical Facilities Corporation Q1 Earnings Surge on Divestiture Proceeds and Organic Growth

    Medical Facilities Corporation Announces 2026 First Quarter Results

    14
← Newer Older →